Ahmed E. Elesawy

518 total citations
19 papers, 429 citations indexed

About

Ahmed E. Elesawy is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ahmed E. Elesawy has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Ahmed E. Elesawy's work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (6 papers) and RNA Interference and Gene Delivery (3 papers). Ahmed E. Elesawy is often cited by papers focused on MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (6 papers) and RNA Interference and Gene Delivery (3 papers). Ahmed E. Elesawy collaborates with scholars based in Egypt, Saudi Arabia and Oman. Ahmed E. Elesawy's co-authors include Mohammed S. Elballal, Mahmoud A. Elrebehy, Ahmed S. Doghish, Ola Elazazy, Al-Aliaa M. Sallam, Reem K. Shahin, Heba M. Midan, Ahmed I. Abulsoud, Abdullah M. M. Elbadry and Sherif S. Abdel Mageed and has published in prestigious journals such as Experimental Cell Research, Life Sciences and International Journal of Biological Macromolecules.

In The Last Decade

Ahmed E. Elesawy

17 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed E. Elesawy Egypt 11 304 290 56 49 49 19 429
Dan‐Ming Wei China 11 182 0.6× 271 0.9× 59 1.1× 33 0.7× 34 0.7× 26 422
Fuchao Ma China 13 223 0.7× 319 1.1× 60 1.1× 28 0.6× 32 0.7× 25 407
Chunjuan Zhao China 9 194 0.6× 257 0.9× 46 0.8× 30 0.6× 22 0.4× 12 360
Guokai Pan China 8 250 0.8× 335 1.2× 49 0.9× 27 0.6× 39 0.8× 10 432
Shijun Wang China 11 212 0.7× 228 0.8× 42 0.8× 82 1.7× 34 0.7× 18 397
Shanshan Zhao China 13 258 0.8× 351 1.2× 40 0.7× 29 0.6× 47 1.0× 27 486
Haitao Zhang China 11 172 0.6× 221 0.8× 53 0.9× 38 0.8× 23 0.5× 25 340
Nader Mansour Samaei Iran 11 356 1.2× 442 1.5× 72 1.3× 30 0.6× 60 1.2× 31 559
Roxana S. Redis United States 7 405 1.3× 440 1.5× 43 0.8× 22 0.4× 22 0.4× 14 544
Yang Shao China 13 424 1.4× 506 1.7× 53 0.9× 53 1.1× 20 0.4× 19 620

Countries citing papers authored by Ahmed E. Elesawy

Since Specialization
Citations

This map shows the geographic impact of Ahmed E. Elesawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed E. Elesawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed E. Elesawy more than expected).

Fields of papers citing papers by Ahmed E. Elesawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed E. Elesawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed E. Elesawy. The network helps show where Ahmed E. Elesawy may publish in the future.

Co-authorship network of co-authors of Ahmed E. Elesawy

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed E. Elesawy. A scholar is included among the top collaborators of Ahmed E. Elesawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed E. Elesawy. Ahmed E. Elesawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Doghish, Ahmed S., et al.. (2025). Role and Significance of MicroRNAs in the Relationship Between Obesity and Cancer. Balkan Medical Journal. 42(3). 188–200.
2.
Hamad, Rabab S., Mai A. Abd‐Elmawla, Ahmed I. Abulsoud, et al.. (2025). Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies. International Journal of Clinical Oncology. 30(10). 1925–1945.
3.
Zewail, Moataz B., et al.. (2025). Investigating the potential of quercetin-loaded chitosan-coated lipid carriers as an oral nanoplatform for depression management. International Journal of Biological Macromolecules. 319(Pt 3). 145569–145569. 2 indexed citations
4.
Elsakka, Elsayed G.E., Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.. (2024). The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies. Experimental Cell Research. 442(2). 114234–114234. 1 indexed citations
5.
Elsakka, Elsayed G.E., Heba M. Midan, Ahmed I. Abulsoud, et al.. (2024). Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer. Experimental Cell Research. 442(2). 114272–114272. 7 indexed citations
6.
Mageed, Sherif S. Abdel, Hanan Elimam, Ahmed E. Elesawy, et al.. (2024). Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3433–3450. 3 indexed citations
7.
Mageed, Sherif S. Abdel, Shereen Saeid Elshaer, Mohammed S. Elballal, et al.. (2024). The emerging role of miRNAs in epilepsy: From molecular signatures to diagnostic potential. Pathology - Research and Practice. 254. 155146–155146. 6 indexed citations
8.
Abulsoud, Ahmed I., Shereen Saeid Elshaer, Nehal I. Rizk, et al.. (2024). Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches. Current Atherosclerosis Reports. 26(8). 395–410. 2 indexed citations
9.
Doghish, Ahmed S., Mohamed A. Ali, Mahmoud A. Elrebehy, et al.. (2023). The interplay between toxoplasmosis and host miRNAs: Mechanisms and consequences. Pathology - Research and Practice. 250. 154790–154790. 18 indexed citations
10.
Doghish, Ahmed S., Mohammed S. Elballal, Ola Elazazy, et al.. (2023). miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses. Pathology - Research and Practice. 245. 154440–154440. 54 indexed citations
11.
Doghish, Ahmed S., Mohammed S. Elballal, Al-Aliaa M. Sallam, et al.. (2023). The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay. Pathology - Research and Practice. 248. 154611–154611. 27 indexed citations
12.
Elesawy, Ahmed E., Ahmed I. Abulsoud, Mohammed S. Elballal, et al.. (2023). miRNAs orchestration of testicular germ cell tumors – Particular emphasis on diagnosis, progression and drug resistance. Pathology - Research and Practice. 248. 154612–154612. 28 indexed citations
13.
Elazazy, Ola, Heba M. Midan, Reem K. Shahin, et al.. (2023). Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications. Pathology - Research and Practice. 246. 154512–154512. 49 indexed citations
14.
Doghish, Ahmed S., Ola Elazazy, Aml Ghanem, et al.. (2023). The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance. Pathology - Research and Practice. 251. 154880–154880. 17 indexed citations
15.
Mohammed, Osama A., Mohammed S. Elballal, Ahmed A. El-Husseiny, et al.. (2023). Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease. Pathology - Research and Practice. 253. 155023–155023. 11 indexed citations
16.
Doghish, Ahmed S., Mohammed S. Elballal, Ola Elazazy, et al.. (2023). The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. Pathology - Research and Practice. 243. 154375–154375. 76 indexed citations
17.
Elballal, Mohammed S., Al-Aliaa M. Sallam, Ahmed E. Elesawy, et al.. (2023). miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses. Pathology - Research and Practice. 245. 154439–154439. 52 indexed citations
18.
Fathi, Doaa, Mohammed S. Elballal, Ahmed E. Elesawy, et al.. (2023). An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. Life Sciences. 322. 121667–121667. 51 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan‐Ming Wei Breakdown of academic impact, for papers by Fuchao Ma Breakdown of academic impact, for papers by Chunjuan Zhao Breakdown of academic impact, for papers by Guokai Pan Breakdown of academic impact, for papers by Shijun Wang Breakdown of academic impact, for papers by Shanshan Zhao Breakdown of academic impact, for papers by Haitao Zhang Breakdown of academic impact, for papers by Nader Mansour Samaei Breakdown of academic impact, for papers by Roxana S. Redis Breakdown of academic impact, for papers by Yang Shao
Rankless by CCL
2026